Design and evaluation of soluble ocular drug insert for controlled release of ciprofloxacin hydrochloride

Drug Development and Industrial Pharmacy

Volumn 32, Issue 4, 2006, Pages 443-448

  Mundada, A S ^a   Shrikhande, B K ^a  

^a RTM NAGPUR UNIVERSITY   (India)

Author keywords

Ciprofloxacin hydrochloride; Controlled release; Gelatin; In vitro and In vivo release; Soluble ocular insert

Indexed keywords

CIPROFLOXACIN; ETHYL CELLULOSE; GELATIN; POLYMER;

ABSORPTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARTMENT MODEL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DESIGN; DRUG RELEASE; DRUG SCREENING; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; MEMBRANE PERMEABILITY; MOISTURE; NONHUMAN; THICKNESS;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; EYE; MEMBRANES, ARTIFICIAL; RABBITS; SOLUBILITY;

EID: 33646484653     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040500534101     Document Type: Article

References (30)

1. Ali, A., & Sharma, S. N. (1991). Fabrication of flow through apparatus for in vitro determination of drugs from ophthalmic preparations. Indian Drugs, 29, 157.
2. Aquil, M. (2005). Advances in ophthalmic drug delivery systems. Part-II. www.pharmainfo.net pp 1-14.
3. Aryata, M., & Sfeir, T. (1981). Bull. Soc. Fr. Ophthalmol., 92, 134.
4. Bawa, G. (1993). Ocular inserts. In Ophthalmic Drug Delivery Systems, Mitra, A. K., Ed.; New York: Marcel Dekker Inc., 223-259.
5. Buri, P. (1985). Voie Ocularie. In Formes Pharmaceutiques Nouvelles, Buri, P., Puisieux, F., Doelker, E., & Benoit, J. P., Eds.; Paris: Lavoisier, 411-438.
6. Chambers, H. F. (2001). Sulfonamides, trimethoprim, and quinolones. In Basic and Clinical Pharmacology, Katzung, B. G., Ed.; New York: McGraw Hill, 799.
7. Chien, Y. W. (1982). Ocular controlled release drug administration. In Novel Drug Delivery Systems, Swarbrick, J., Ed.; New York: Marcel Dekker, 13-48.
8. Chien, Y. W. (1993). Ocular drug delivery and delivery systems. In Novel drug delivery systems. New York: Marcel Dekker Inc., 269-301.
9. Chiou, G. C. Y., & Watanabe, K. (1982). Drug delivery to the eye. Pharm. Ther., 17, 269-278.
10. Dandagi, P. M., Manvi, F. V., Patil, M. B., Mastiholimath, V. S., & Rathod, R. (2004). Development and evaluation of ocular films of cromolyn sodium. Indian J. Pharm. Sci., 66(3), 309-312.
11. Dhanaraju, M. D., Sivakumar, V. R., Subhashree, R., & Bhaskar, K. (2002). Bioadhesive ocusert matrix for ophthalmic administration of ciprofloxacin hydrochloride. Indian Drugs, 39, 222-224.
12. Draize, J. H., Woodward, G., & Calvery, H. O. (1944). Methods for the study of irritation and toxicity of substance applied topically to the skin and mucous membrane. J. Pharmacol. Exp. Ther., 82, 377-390.
13. Graber, H. (1991). Rational antibiotic therapy; New drugs, changing concepts. The Eastern Pharmacist, 7, 25-30.
14. Grass, G. M., & Robinson, J. R. (1984). Relationship of chemical structure to corneal penetration and influence of low viscosity solution on ocular bioavailability. J. Pharm. Sci., 73, 1021-1027.
15. Gurtler, F., & Gurny, R. (1995). Patent literature review of ophthalmic inserts. Drug Dev. Ind. Pharm., 21, 1-18.
16. Jayaprakash, S., James, C. C., Maria Gerald Rajan, N. S., Saisivam, S. S., & Nagarajan, M. (2000). Design and evaluation of ketorolac tromethamine ocuserts. Indian J. Pharm. Sci., 62(5), 334-338.
17. Lee, V. H. L. (1990). Review: New directions in optimization of ocular drug delivery. J. Ocul. Pharmacol., 6, 157-164.
18. Lee, V. H. L., & Robinson, J. R. (1986). Review: Topical ocular drug delivery: Recent developments and future challenges. J. Ocul. Pharmacol., 2, 67-108.
19. Maurice, D. M. (1987). Kinetics of topically applied drugs. In Ophthalmic Drug Delivery, Biopharmaceutical, Technological, and Clinical Aspects. Fidia Research Series. vol. II, Saettone, M. F., Bucci, P., & Speiser, P., Eds.; Padova, Italy: Liviana Press, 19-26.
20. Mikkelson, J. (1984). Ophthalmic drug delivery. Pharm. Technol., 91, 89-98.
21. Pharmacopoeia of India. (1996). 4th edition, vol. I. Controller of publication, Ministry of Health and Family Welfare, Government of India, New Delhi. 190.
22. Richardson, K. T. (1975). Ocular microtherapy: membrane controlled drug delivery. Arch. Ophthalmol., 93, 74-86.
23. Robinson, J. C. (1993). Ocular anatomy and physiology relevant to ocular drug delivery. In Ophthalmic drug delivery, Mitra, A. K., Ed.; New York: Marcel Dekker Inc., 32.
24. Saettone, M. F. (1993). Solid polymeric inserts/disks as drug delivery devices. In Biopharmaceutics of ocular drug delivery, Edmon, P., Ed.; Boca Ratton, FL, USA: CRC press, 61-79.
25. Saettone, M. F., & Saleminen, L. (1995). Ocular inserts for topical delivery. Adv. Drug Delivery Rev., 16, 95-106.
26. Saettone, M. F., Giaccinni, B., Ravecca, S., La Marca, F., & Tota, G. (1984). Polymers effect on ocular bioavailability - the influence of different liquid vehicles on mydratic response of tropicamide in humans and in rabbits. Int. J. Pharm., 20, 187-202.
27. Saisivam, S., Manikandav, R. V. M., & Nagarajan, M. (1999). Design and evaluation of ciprofloxacin hydrochloride ocuserts. Indian J. Pharm. Sci., 61(1), 34-38.
28. Salminen, L. (1987). "Pilocarpine Inserts: Experimental and Clinical experiences. In Ophthalmic Drug Delivery, Biopharmaceutical, Technological and Clinical aspects, Fidia Research Series, Saettone, M. F., Bucci, P., & Speiser, P., Eds.; Padova, Italy: Liviana Press, 161-170.
29. Sane, R. T., Tirodkar, V. B., Desai, A. J., Patel, M. K., & Kulkarni, U. P. (1992). Indian Drugs, 29, 489.
30. Shell, J. W. (1980). New ophthalmic drug delivery systems. In Ophthalmic Drug Delivery Systems, Robinson, J. R., Ed.; Washington, D.C.: American Pharmaceutical Association, 145-157.